Steve Blackburn Promoted to Chief Operating Officer of Priority OnDemand
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Priority OnDemand (“Priority” or “the company”) announced today that Steve Blackburn has been promoted to Chief Operating Officer....
Month: January 2022
Cannabis Suisse Corp. Reports on the Relevance of the Development of the IT Project “Cannabis Life”
DIETIKON, SWITZERLAND / ACCESSWIRE / January 18, 2022 / Cannabis Suisse Corp. (OTC PINK:CSUI), registered in the state of Nevada,...
AlzeCure Gets Late-Breaking Abstract on NeuroRestore ACD856 Clinical Data Accepted to AD/PD 2022 Conference
STOCKHOLM, SWEDEN / ACCESSWIRE / January 18, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases
COLLABORATION LEVERAGES EVOTEC'S BROAD METABOLIC EXPERTISE AND UNIQUE KIDNEY DISEASE PATIENT DATABASE AS WELL AS INTEGRATED DATA-DRIVEN DRUG DISCOVERY AND...
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million ( € 66.9 million)Anticipated 2022 Monjuvi U.S. net product...
Retrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology...
Empatho Holdings Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - January 17, 2022) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the...
Restrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of an abstract presented last Saturday at the Society for Technology...
Britannia Secures Agreement with RST to Supply UK CBD Market
Remediation Sciences and Technology supplies some of the world's largest CPG and cannabis companies with cannabis extracts RST will provide...
Cloud DX Announces Voluntary Extension of Lock-up Agreements with Company Insiders
News in SummaryCloud DX insiders (as defined by the TSX Venture Exchange) holding approximately 33% of the issued and outstanding...
CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 17, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing...
Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film, microneedle patch and biosynthesis...
Extendicare Announces January 2022 Dividend of C$0.04 per Share
MARKHAM, Ontario, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as...
Christina Lake Cannabis to Present at the KCSA Cannabis Virtual Investor Conference; Announcement of Special Meeting of Class B Preferred Shareholders
CLC invites individual and institutional investors, as well as advisors and analysts, to attend our interactive presentation real-time on VirtualInvestorConferences.comVANCOUVER,...
Vigil Health Solutions to be Acquired by ASSA ABLOY
VICTORIA, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSXV: VGL) announced...
Evelo Biosciences Presents Data on EDP1815 Mechanism of Action and Supporting Ongoing Clinical Development for Inflammatory Diseases
CAMBRIDGE, Mass., Jan. 17, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing SINTAX™ medicines...
Immuron Receives AUD $306,154 R&D Tax Concession Refund
MELBOURNE, Australia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill
Clinical trial begins in the UK to investigate 3-in-1 high blood pressure pill 500 UK patients to be treated as...
John Dawson to retire from Oxford Biomedica
John Dawson to retire from Oxford Biomedica Oxford, UK – 17 January 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the...